Saturday, October 3, 2026

USD/CNH Bullish Momentum: 0.804% Up In The Last 24 Hours

ViaNews Editorial Team

February 24, 2023

USD/CNH Bullish Momentum: 0.804% Up In The Last 24 Hours

(VIANEWS) - USD/CNH (USDCNH) has been up by 0.8037% for the last session's close. At 09:07 EST on Friday, 24 February, USD/CNH (USDCNH) is $6.97.

USD/CNH (USDCNH) Range

Concerning USD/CNH's daily highs and lows, it's 3.558% up from its trailing 24 hours low of $6.73 and 2.376% up from its trailing 24 hours high of $6.81.

USD/CNH's yearly highs and lows, it's 0.903% up from its 52-week low and 0.046% down from its 52-week high.

News about

  • Usd/jpy retreats further from two-month highs, eyes on FOMC minutes. According to FXStreet on Wednesday, 22 February, "The USD/JPY is falling on Wednesday, retreating after hitting on Tuesday at 135.22, the highest level since mid-December. ", "Although the USD is finding support on the market's acceptance that Fed rates will likely stay higher for longer on the back of resilience in the US economy, we see potential for USD/JPY to edge moderately lower on a 12 month view on the assumption that the BoJ makes some cautious steps towards reversing its ultra-accommodative policy", wrote Rabobank's analysts. "
  • Usd/jpy pauses three-day uptrend near 135.00 as yields portray anxiety ahead of fed minutes. According to FXStreet on Wednesday, 22 February, "Moving on, a cautious mood ahead of the key data/events could entertain USD/JPY traders before the Fed Minutes. ", "A daily closing beyond the 100-day Exponential Moving Average (EMA), around 134.75 by the press time, directs USD/JPY buyers towards mid-December 2022 tops surrounding 138.20."
  • Usd/jpy price analysis: retreats towards 134.00 key support. According to FXStreet on Wednesday, 22 February, "Given the overbought RSI (14) also assenting to the USD/JPY pullback, the intraday sellers are likely to have a bit longer good time.", "However, a convergence of the monthly resistance-turned-support line and an upward-sloping trend line from February 03, close to 134.00 at the latest, appears a tough nut to crack for the USD/JPY bears."
  • Usd/jpy to tick down toward 125 over coming months – rabobank. According to FXStreet on Wednesday, 22 February, "Although the USD is finding support on the market's acceptance that Fed rates will likely stay higher for longer on the back of resilience in the US economy, we see potential for USD/JPY to edge moderately lower on a 12-month view on the assumption that the BoJ makes some cautious steps towards reversing its ultra-accommodative policy."

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com